Small Cap Value Report (Tue 23 Jan 2024) - AWE, BMK, ELCO, HAT

Good morning from Paul amp; Graham!

---

Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to review trading updates amp; results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it’s anybody’s guess what direction market sentiment will take amp; nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps (usually) between £10m and £1bn. We usually avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed – please be civil, rational, and include the company name/ticker, otherwise people won’t necessarily know what company you are referring to.

What does our colour-coding mean? Will it guarantee instant, easy riches? Sadly not! Share prices move up or down for many reasons, and can often detach from the company fundamentals. So we’re not making any predictions about what share prices will do.

Green (thumbs up) – means in our opinion, a company is well-financed (so low risk of dilution/insolvency), is trading well, and has a reasonably good outlook, with the shares reasonably priced. OR it’s such deep value that we see a good chance of a turnaround, and think that the share price might have overshot on the downside.

Amber – means we don’t have a strong view either way, and can see some positives, and some negatives. Often companies like this are good, but expensive.

Red (thumbs down) – means we see significant, or serious problems, so anyone looking at the share needs to be aware of the high risk. Sometimes risky shares can produce high returns, if they survive/recover. So again, we’re not saying the share price will necessarily under-perform, we’re just flagging the high risk.

Links:

Paul amp; Graham’s 2024 share ideas - live price-tracking spreadsheet (2 separate tabs at bottom),

Frozen SCVR summary spreadsheet for calendar 2023.

New SCVR summary spreadsheet from July 2023 onwards.

Paul’s podcasts (weekly summary of SCVRs amp; macro views) – or search on any podcast provider for “Paul Scott small caps” – eg Apple, Spotify.

---

Agenda

Companies reporting today -

Other mid-morning movers (with news) at 10:25 -

Cornerstone FS (LON:CSFS) – up 9% to 38p – deal with Mastercard to launch corporate cards in Q3 2024.

Big Technologies (LON:BIG) – up 9% to 114.5p – CEO buys 300k at 106.5p, total held 73.4m (25.3%), recent PW.

Esken (LON:ESKN) – down 48% to 48% – serious dispute over £194m conv loan. Equity worthless possibly?

---

Summaries

Alphawave IP (LON:AWE) – up 16% y’day to 134p (£961m) – Trading Update – Paul – RED

My first review of this (one of many) disastrous 2021 floats. I don’t understand its products or tech, but I can see plenty of flaws in the figures. So it’s not for me. I think this chip designer needs to establish a more reliable track record of profit/cashflow before it can be viewed positively here. Shares bounced strongly yesterday on an in line 2023 trading update. Will any of the $87m EBITDA turn into cash though? It didn’t in H1, which was heavily cash consuming.

Benchmark Holdings (LON:BMK) – up 17% y’day to 41p (£303m) – Strategic Review amp; FSP – Paul – AMBER/RED

Puts itself up for sale, as management think shares are undervalued. I’m struggling to justify a valuation anywhere near the existing high price, given its years of losses, and indebted balance sheet. So it will be interesting to see how this pans out. 3 major shareholders hold almost 3/4 of the equity, so it’s quite illiquid.

Eleco (LON:ELCO) – up 5% to 91p (£76m) – Year-end trading update (slight beat) – Paul – AMBER

Slightly beats 2023 forecast, but that’s come from trimming costs, as revenue is slightly below forecast. About half the growth is coming from acquisitions. Balance sheet has plenty of cash thanks to favourable up-front payments by customers, but balance sheet overall is slightly negative NTAV. Overall I think it looks a nice enough business, but as mentioned before, fully priced for now, hence me sticking at amber. Could grow into the valuation though, if forecast growth is achieved or beaten.

H amp; T (LON:HAT) – down 15% to 339p (£149m) – Trading Update (profit warning) – Graham – GREEN on fundamentals, BLACK (profit warning flag) for spreadsheet

Hamp;T reveals that December was a tough month for it from a retailing perspective, as buyers chose cheap, low-margin new items over more expensive pre-owned items. I remain a fan of this company and see an opportunity here at 6x earnings that warrants further investigation.

---

Paul’s Section: Alphawave IP (LON:AWE)

Up 16% y’day to 134p (£961m) – Trading Update – Paul – RED

This is a new company for the SCVR, so it will be good to get something into our system here. It was a £3bn 2021 tech float at 410p/share, so obviously the shares have plummeted since. Note the prospectus says selling shareholders took out £495m in the IPO. Still, it doesn’t seem to want to go below 100p more recently, maybe a base forming here?

Note that the rot seemed to set in after the FT published a critical article in Sept 2023 about alleged undisclosed related party deals, which the company denied here.

What does it do? Search me! Press articles describe it as a “chip designer”. This is the company’s self description today -

Alphawave Semi is a global leader in high-speed connectivity for the world’s technology infrastructure. Faced with the exponential growth of data, Alphawave Semi’s technology services a critical need: enabling data to travel faster, more reliably and with higher performance at lower power. We are a vertically integrated semiconductor company, and our IP, custom silicon, and connectivity products are deployed by global tier-one customers in data centers, compute, networking, AI, 5G, autonomous vehicles, and storage. Founded in 2017 by an expert technical team with a proven track record in licensing semiconductor IP, our mission is to accelerate the critical data infrastructure at the heart of our digital world. To find out more about Alphawave Semi, visit: awavesemi.com

I don’t understand what the company does, and today’s update very much blinds me with science. So I’m going to purely look at the figures, which I can understand.

I have to get almost to the end of the update today to find something I can lock onto, this bit -

The outlook for 2023 remains unchanged. Alphawave Semi expects 2023 revenue of US$340m to US$360m and adjusted EBITDA of approximately US$87m (or approximately 25% of revenue), which is at the mid-point of the revenue guidance range.  

Despite the uncertain macroeconomic environment, our growing pipeline reflects positive secular growth trends in data infrastructure markets and the continued investment in next-generation AI- centric connectivity solutions. This, combined with our talented team and strong balance sheet, give us confidence in our future.

Broker update – I don’t have access to anything, so instead will have a look at the last interim results to get a flavour amp; compare with the FY guidance above.

H1 Results to 30 June 2023 -

Profit amp; loss account -

Revenue $187m (up 228% due to substantial “Royalties and silicon” starting – from China)

Adj EBITDA $32.4m

Massive share-based payment of $18.5m in H1, which causes the losses below:

Operating loss $(2.6)m

H1 Loss before tax of $(11.2)m – after $7.6m H1 finance charge due to net debt, plus a $2.7m charge for a loss-making JV.

Balance sheet – at 30 June 2023 –

NAV $487m, includes goodwill $332m and intangible assets $180m, so NTAV is $(24)m.

Net debt of $100m at 30/6/2023 compares with net cash of $452m a year earlier, so where did all the cash go?

Receivables $100m + Accrued revenue (same thing) $67m is equivalent to almost all of H1 revenues, and a lot of those revenues originate in China, so this makes me very uneasy.

Cash of $123m is more than offset by $223m “Loans and borrowings”, so net debt of $100m. Note 18 in H1 results shows this is a $100m 5-year term loan plus an RCF from a banking syndicate.

NB it breached a banking covenant in June 2023, with an amended agreement signed in Sept 2023 relaxing the covenants. Still not a good look. In the going concern statement it blames this on customers paying slowly (higher deferred revenue) and high Ramp;D spending. It gave itself a clean going concern review in June 2023.

Cashflow statement - for H1 2023 is poor, showing it consuming cash. One half year isn’t enough to draw a firm conclusion, but I don’t like the look of this.

Cash generation in H1 was $29m, but then $(60)m was absorbed by working capital, mainly “deferred revenue” creditor which shrank from $92m to $42m.

So operating cashflow was negative $(31)m vs positive $32m in H1 LY. Swings and roundabouts maybe, but it nets off to almost zero, suggesting to me this is not a cash generative business yet.

Then there are further H1 cash outflows, $5m in tax, $13m capex, $25m in capitalised development spending (just in H1), and $4m invested in a JV.

Overall, cash was considerably depleted from $186m to $123m, and borrowings increased a little too. Not a pretty picture, so an amber warning from me here on negative cashflow.

Paul’s opinion – all I’m talking about here are the numbers, as I don’t have any understanding of what the company does, or its competitive position.

My concerns are -

EBITDA does not turn into cashflow, so far anyway. Note that $32m adj EBITDA in H1 was more than exceeded by capex amp; capitalised development spend.

Also working capital absorbed a lot of cash, and it seems the Chinese customers are slow payers, quelle surprise! Anything that relies heavily on selling things into China is something I would rather avoid, for a variety of reasons, it often seems to cause problems for UK companies and investors.

The balance sheet is weak, and heavily reliant on bank facilities.

Breaching covenants in June 2023 suggests weak financial controls, and performance not going to plan. So although it was resolved with amendments, it’s a warning I think.

Shareholders took cash out in the float, but it’s still dominated by 2 shareholders with a combined 50.7%, which is too much, especially combined with the China connections.

On the upside, the products/services could be the best thing since sliced bread walked through the door, I have no idea on that. But the numbers alone don’t give me the confidence to want to dig any deeper.

So overall I’m going to view this as RED, based on the facts amp; figures at this point in time.

Once it’s established a better financial track record of real profits and cashflow, which it hasn’t yet, then I’ll be happy to look at it with fresh eyes in future.

Stockopedia’s computers share my unease -

It qualifies for 2 short selling screens, and only 1 long screen -

So I think it’s clear that both man and machine want to see a longer track record from AWE before getting keen on the shares. The trouble is, we might miss out on a bull run if we sit on the sidelines, so that’s the trade off isn’t it.

---

Benchmark Holdings (LON:BMK)

Up 17% y’day to 41p (£303m) – Strategic Review amp; FSP – Paul – AMBER/RED

Benchmark Holdings plc (“Benchmark” or the “Company”), is a market leading aquaculture genetics, nutrition, and health business, delivering advanced biotechnology products and solutions that enable the aquaculture industry to improve its productivity and sustainability, helping address the need for sustainable aquatic food to feed a growing global population.  

The Company is a supplier of choice for aquaculture producers worldwide with market leading positions in genetics, early-stage nutrition and sea lice solutions and well invested infrastructure to support growth. The Company’s specialised mission critical products and solutions reflect decades of invested capital, IP and expertise, which the Board believes are very difficult to replicate.

BMK management seem to think its shares are undervalued, and so has put itself up for sale, through the Formal Sale Process under the Takeover Panel rules. So expect a deluge of announcements each day as the disclosure obligations move down to 1% holdings, and changes to positions above that size. I often have to take companies off my email RNS alerts watchlist once offer periods begin, due to the volume of trivial announcements.

It claims a successful financial track record -

Management actions over the last three years have delivered substantial revenue growth and improvement in profitability and cash conversion. Since FY20, Benchmark’s revenue from continuing operations has grown from £105.4m to £169.5m in FY23 and Adjusted EBITDA has increased from £15.5m to £35.5m. The Company is well positioned with a strong balance sheet and significant headroom to grow within its existing markets, as well as multiple potential avenues for expansion.

Although it doesn’t actually make any real profits – so I’d say the financial track record has been lousy, and doesn’t even come close to justifying a £300m market cap.

The £35.5m adj EBITDA mentioned above turned into a £12.7m loss before tax. The same thing happens every year – statutory losses, not profits.

The company says it has a strong balance sheet, but it doesn’t! Net debt was £65.5m at 30/9/2023, which brings hefty finance costs to the Pamp;L.

I don’t understand why it pays heavy taxation, considering it’s loss-making?

Paul’s opinion – this has always been a jam tomorrow company, and I’m amazed investors have been so patient with years of continuing losses, cash outflows, and several equity fundraisings.

It must boil down to investors believing that the company has special know-how that might eventually result in it making some profit, perhaps?

As I say above, the existing valuation doesn’t make any sense whatsoever to me, so why would anyone be prepared to pay even more for it, in a sale process?

There’s not much liquidity in this share, due to 3 dominant shareholders, so maybe taking it private might make some sense? I’d be worried that could happen at a discount, rather than a premium though.

I see Harwood increased in Nov 2022, and they’re certainly not fools, so there must be something interesting at BMK that is not obvious from the numbers -

On the upside, sometimes companies with unique technology attract high valuations that are not necessarily linked to financial performance. Maybe this could turn out to be such a case?

Time will tell, I don’t know how this situation will end up, your guess is as good as mine!

Given that it’s so overvalued on poor fundamentals, I have to go AMBER/RED.

10-years as a listed company, and it’s gone nowhere -

---

Eleco (LON:ELCO)

Up 5% to 91p (£76m) – Year-end trading update (slight beat) – Paul – AMBER

The Board of Eleco plc (AIM: ELCO), the specialist software provider for the built environment, is pleased to provide a trading update for the year ended 31 December 2023, based on unaudited management accounts for the period.

I have a generally favourable impression of this software business, having followed it for years. It bombed out after the 2008 GFC (great financial crisis), bottoming out around 7p, so has been a lovely 10+ bagger since then (not far off a 20-bagger during the peak 2021 valuation of c.132p).

Eleco seems a good company, churning out pretty reliable profits. Although I’ve often placed a question mark over its high valuation, eg when reviewing here on 11/5/2023, I could only go to amber then because any higher didn’t seem justified since profit had only gone sideways in the last 5 years.

The bull case is that a long transition to more reliable SaaS recurring revenues (now up to 74% of total revenues) has suppressed short term profits in return for more reliable long-term recurring revenues. Lots of software companies have done a similar thing, but 5-years is a long time for investors to wait.

On to today’s trading update for FY 12/2023.

Record Recurring Revenue Growth

ARR at 31 December 2023 was approximately £22.6m (at 31 December 2022: £18.2m) an increase of 24%.

That is good, and gives nice visibility. Although almost half the growth has come from an acquisition of BestOutcome.

Total revenue for FY 12/2023 is now £28.0m.

What about profitability? The CEO says -

…profitability is expected to be ahead of consensus. This reflects our strategic switch to a SaaS business model and our focus on higher margin core products, and the discontinuation of products that were not contributing to the future of the Group.

Cavendish updates us (many thanks), and its revised FY 12/2023 actually show a reduction in forecast revenues from £28.7m to £28.0m (6% Y-on-Y growth instead of 8% previously forecast). This revenue shortfall is recouped only through lower costs. The table shown by Cavendish shows an increase in forecast adj EBITDA from £5.8m to £6.0m, but actually both figures arrive at £5.9m, flat. So there must be some rounding differences in the table, or a formula is wrong in their spreadsheet! 

I hope Cavendish don’t mind me including the excerpt below, and of course I’ll remove it if they complain -

Adj EPS is revised from 3.7p to 3.8p, and given that this has been achieved by lower costs, on lower revenue than forecast, I don’t really see this as ahead of expectations – it’s more realistic to see this as in line, thanks to some costs coming in a bit lower than expected.

I’ll call it a “slight beat” so I don’t have a riot on my hands from ELCO shareholders!

Forecasts for 2024 and 2025 are actually slightly trimmed today for revenue (down 3% in both years compared with previous forecasts). EBITDA is unchanged in the 2024 amp; 2025 forecasts, but that’s only been achieved by cutting forecast costs by 4%. So it looks a rather defensive minor move on forecasts, although to be fair, the numbers are still showing decent earnings growth year-on-year, with this forecast progression -

FY 12/2023: 3.8p adj dil EPS

FY 12/2024: 4.6p

FY 12/2025: 6.0p

I don’t think there’s any point in looking any further forward into the future, although since ELCO has c.74% recurring revenues, it’s easier amp; safer to forecast than for many other shares. So even if a profit warning were to happen, it probably wouldn’t be a major miss.

Cash looks healthy -

Cash as at 31 December 2023 was £10.9m reflecting strong cash generation outside of an acquisition payment and related costs of £3.8m and increased Interim, Final and Special Dividends.

However, bear in mind that more than all the cash all comes from favourable working capital cycle – getting paid up-front by customers. Eg at 30 June 2023, cash was £9.4m, but deferred income creditor was £(12.0)m.

Overall NTAV was slightly negative, at £(1.3)m. So it’s not actually a strong balance sheet, it’s adequate thanks to a favourable working capital cycle.

We really need to know the average daily net cash figure, plus the annual peak and trough, to be able to properly assess the validity of its cash position. That’s true for all companies. Are the period end cash figures untypical seasonal highs, or are they normal at that level throughout the year? We don’t know, it’s a big gap in current financial reporting requirements.

My worry is that if ELCO keeps making acquisitions using cash paid up-front by customers, it would reduce NTAV further into negative territory, thus potentially making the share more risky if something bad happened.

Expansion into the USA sounds very interesting, with gt;40 new clients. That’s something I’d be interested in hearing more about when the full results are published. Obviously a huge market, so if ELCO can succeed there, very tough to do of course for overseas companies, then it might be transformative long-term.

Outlook -

“We continue to see exciting opportunities with the long-term market growth trends and drivers in the geographies we operate in. Given our established positioning and cash-generative SaaS business model, we are confident of another year of strong organic growth, supplemented by further acquisitions, to widen our international reach and customer-focused capabilities.”

Paul’s opinion - this looks quite good. There are some nice positives covered above, but as before, valuation seems up with events. Hence I’ll stick with AMBER. Just to emphasise, I don’t see anything wrong with ELCO’s numbers, my only quibble is paying a high-ish multiple for relatively modest organic growth – remember that acquisitions are boosting the growth numbers. 

Although taking a 2-year view, if it hits 2024 amp; 2025 forecasts, then the share would probably have decent upside, as it grows into the valuation. So maybe something to consider as a long-term investment, if your own research makes you feel positive about it meeting or hopefully beating forecasts in future.

---

Graham’s Section: H amp; T (LON:HAT)

Share price: 339p (-15%)

Market cap: £149m

Hamp;T Group Plc (“Hamp;T” or “the Group”), the UK’s largest pawnbroker and a leading retailer of high quality new and pre-owned jewellery and watches, today provides an update following completion of the financial year ended 31 December 2023.

This is a surprising (to me) profit warning from the UK’s largest pawnbroker.

2023 profits are up 40% compared to the prior year, but retail conditions pre-Christmas were “challenging”, particularly in December. So despite strong year-on-year growth, the profit result is still 10% below market forecasts.

With thanks to Research Tree and Shore Capital: the old PBT forecast for 2023 was £29.5m, whereas the new forecast is £26.6m.

Shore Capital have also reduced their PBT forecasts for 2024 (by 9%) and for 2025 (by 10%).

Let’s explore the trading update a bit more:

Pawnbroking: continues to go from strength to strength. The pledge book is up 30% year-on-year to £131m, ahead of expectations. The characteristics and performance of loans are unchanged, i.e. average loan size £201, redemption rates 85%, loan to value 65%.

As an aside, perhaps the warnings in recent months from HAT on problems in the luxury watch market should have been taken as a bad omen for Watches of Switzerland (LON:WOSG) investors? HAT is now more cautious when it comes to lending on watches, and watches are now just 15% of the pledge book (previously 17%).

Retail: Q4 was “challenging”, due to the pressures on disposable income. More items were sold than the previous year, but “customers displayed caution in their spending, with a significant shift towards lower priced items”. Customers favoured cheap, new items over more expensive pre-owned items, and Q4 revenues fell 3% year-on-year.

FX/Holiday Money: revenues are up 11% and a “click and collect” service launched in June 2023. It seems to be making good progress, but “it is taking longer than anticipated to achieve forecast volumes and revenues.”

Gold purchasing: up 18% at consistent margins.

Costs: the 10% rise in minimum wage from April 2024 is flagged.

CEO comment: addresses the challenging retail conditions

We believe, despite this challenging backdrop, that we have the right product offering and have continued to invest in our store estate and our technology platforms.

Graham’s view

I’m a long-term fan of this business and I’m disappointed for shareholders that they’ve seen such limited share price progress. At 326p, the shares are back at levels they first reached in September 2017.

Here’s a 5-year chart:

I used to hold this as my largest position. One of the reasons I no longer felt compelled to continue holding it was a belief that it was struggling to do well in terms of ROCE/ROE. Here are those latest quality metrics according to Stockopedia:

As you can see, returns have been good but not “great”.

However, I still view this as a really solid business and am struggling to understand this valuation. Even after today’s downgrades, the company is still forecast to generate an adjusted PBT of £33.5m in the current year, vs. a market cap of less than £150m.

At a 25% corporate tax rate, we have an adjusted PAT of £25m, meaning that the shares are trading at 6x adjusted earnings (note that adjustments were ZERO in 2022, i.e. adjusted profits were the same as actual profits).

At 6x earnings, how can I not give this stock the thumbs up?

To summarise, the bear points are:

• Exposed to retailing sentiment which has been difficult.

• Cost inflation, particularly minimum wage.

• Unexciting return metrics.

Against that, you have:

• The biggest pawnbroking book in the country, by a mile.

• A very long track record of responsible and profitable operations.

• An earnings multiple of 6x.

(Paul adds: the first profit warning from my top 20 ideas for 2024, drat! Still, it’s fairly mild, and as readers have commented below, why did the company guide brokers to set forecasts so high in the first place? The reduced outcome announced today is still an excellent improvement on last year’s profits. We also have a bulletproof balance sheet, with nearly the whole market cap now supported by NTAV. The share price has fallen from 490p peak in the last 3 months, to just 344p today. I think that actually makes it more appealing overall as a value share. So for me, this profit warning is very much glass half full, not half empty. I don’t see anything wrong with the core business, it’s more a case of overly ambitious forecasting, creating the illusion of under-performance, in what has actually proven to be a good year in 2023. So I very much agree with Graham’s view that it’s GREEN on fundamentals)

Stockopedia

Source: https://www.stockopedia.com/content/small-cap-value-report-tue-23-jan-2024-awe-bmk-elco-hat-986724/